Medtronic (NYSE:MDT) today announced real-world data supporting the use of its smart insulin pen and CGM sensor combination.

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

smart insulin pens are becoming an essential component of digital healthcare strategies. Integration with wearable devices and electronic health records (EHRs) supports personalized treatment plans.

Specialty Care Centers – Focus on personalized diabetes treatment programs. Higher initial costs compared to traditional insulin pens. Need for stronger data security and privacy measures in connected ...

Merilog is available in a 3 mL prefilled pen and a 10 mL vial, joining two long-acting insulin biosimilars approved by the FDA in 2021. Merilog, a rapid-acting human insulin analog, is the first ...